Download All Case Studies - Prologis
Download All Case Studies - Prologis
Download All Case Studies - Prologis
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The Requirement<br />
Teva UK, a division of Teva Pharmaceutical Industries,<br />
decided to move its head office and logistics centre to a new<br />
flagship building in West Yorkshire.<br />
The company, which is one of the largest generic<br />
pharmaceutical companies in the world, needed more space<br />
to accommodate its expanding UK business and high quality<br />
facilities to provide the best possible customer service.<br />
The Solution<br />
<strong>Prologis</strong> acquired a site at Glasshoughton on the junction of<br />
the M62 and the A1 trunk road and designed a 262,000 sq ft<br />
facility to meet Teva’s precise brief.<br />
The building, which includes 60,000 sq ft of offices, was<br />
designed to reflect its UK head office function, while the<br />
warehouse was specifically designed for pharmaceutical<br />
storage and distribution.<br />
The project included a £6 million generic and specialist fitout,<br />
including dual systems for all environmental controls to<br />
provide back-up should any of the equipment fail.<br />
The offices were fully fitted, leaving only the furniture to<br />
be provided by Teva. In the warehouse, only the specialist<br />
material handling equipment (MHE) was installed by<br />
Teva and <strong>Prologis</strong> ensured that all systems had a high<br />
degree of tolerance to ensure a smooth integration with the<br />
MHE installation.<br />
www.prologisglasshoughton.co.uk<br />
The Result<br />
The project was completed within a tight timescale to<br />
allow Teva to test run the facility, ensuring 100% accuracy<br />
in product delivery.<br />
“<br />
The new site will bring big improvements for our<br />
customers, as we finally have the space and facilities<br />
to provide the best possible service.<br />
”<br />
John Beighton, Managing Director, Teva UK Limited.<br />
CASE STUDY